{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T09:13:18Z","timestamp":1777540398529,"version":"3.51.4"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12879-017-2708-y","type":"journal-article","created":{"date-parts":[[2017,9,13]],"date-time":"2017-09-13T09:30:41Z","timestamp":1505295041000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Routine monitoring and assessment of adults living with HIV: results of the British HIV Association (BHIVA) national audit 2015"],"prefix":"10.1186","volume":"17","author":[{"name":"on behalf of the BHIVA Audit and Standards Sub-Committee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4058-6715","authenticated-orcid":false,"given":"A.","family":"Molloy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Burns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Freedman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,9,13]]},"reference":[{"key":"2708_CR1","unstructured":"Public Health England. HIV in the UK \u2013 situation report 2015 incidence, prevalence and prevention. Prot Improv Nations Heal. 2015;1(1):1\u201320.  https:\/\/www.gov.uk\/government\/organisations\/public-health-england  ."},{"key":"2708_CR2","unstructured":"Public Health England, 2015. HIV New Diagnoses, Treatment and Care in the UK 2015 report: data to end 2014. \nhttps:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/469405\/HIV_new_diagnoses_treatment_and_care_2015_report20102015.pdf\n\n."},{"issue":"8","key":"2708_CR3","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1097\/QAD.0000000000000243","volume":"28","author":"MT May","year":"2014","unstructured":"May MT, Gompels M, Delpech V, et al. Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy. AIDS. 2014;28(8):1193\u2013202. doi:\n10.1097\/QAD.0000000000000243\n\n.","journal-title":"AIDS"},{"issue":"9939","key":"2708_CR4","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0140-6736(14)60604-8","volume":"384","author":"CJ Smith","year":"2014","unstructured":"Smith CJ, Ryom L, Weber R, et al. Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:a:D): a multicohort collaboration. Lancet (London, England). 2014;384(9939):241\u20138. doi:\n10.1016\/S0140-6736(14)60604-8\n\n.","journal-title":"Lancet (London, England)"},{"issue":"12","key":"2708_CR5","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1093\/cid\/ciu701","volume":"59","author":"J Schouten","year":"2014","unstructured":"Schouten J, Wit FW, Stolte IG, et al. Cross-sectional comparison of the prevalence of age-associated comorbidities and their risk factors between HIV-infected and uninfected individuals: the AGEhIV cohort study. Clin Infect Dis. 2014;59(12):1787\u201397. doi:\n10.1093\/cid\/ciu701\n\n.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"2708_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1468-1293.2011.00971.x","volume":"13","author":"D Asboe","year":"2012","unstructured":"Asboe D, Aitken C, Boffito M, et al. British HIV Association guidelines for the routine investigation and monitoring of adult HIV-1-infected individuals 2011. HIV Med. 2012;13(1):1\u201344. doi:\n10.1111\/j.1468-1293.2011.00971.x\n\n.","journal-title":"HIV Med."},{"key":"2708_CR7","unstructured":"British HIV Association Audit and Standards Sub-Committee. Routine monitoring and assessment of adults with HIV. \nhttp:\/\/bhiva.org\/documents\/Conferences\/Autumn2015\/Presentations\/151112\/AoifeMolloy.pdf\n\n (accessed 21 Oct 2016)."},{"key":"2708_CR8","doi-asserted-by":"crossref","unstructured":"Michael S, Gompels M, Sabin C, Curtis H, May MT. Benchmarked performance charts to improve the effectiveness of feedback of audit data in HIV care. BMC Health Services Research.\u00a02017;17:506.\u00a0\nhttps:\/\/doi.org\/10.1186\/s12913-017-2426-6\n\n.","DOI":"10.1186\/s12913-017-2426-6"},{"issue":"3","key":"2708_CR9","doi-asserted-by":"publisher","first-page":"e85","DOI":"10.1097\/QAI.0000000000000634","volume":"69","author":"JY Ahn","year":"2015","unstructured":"Ahn JY, Boettiger D, Law M, et al. Implementation and operational research: effects of CD4 monitoring frequency on clinical end points in clinically stable HIV-infected patients with viral suppression. J Acquir Immune Defic Syndr. 2015;69(3):e85\u201392. doi:\n10.1097\/QAI.0000000000000634\n\n.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"9","key":"2708_CR10","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1086\/496984","volume":"41","author":"PE Sax","year":"2005","unstructured":"Sax PE, Islam R, Walensky RP, et al. Should resistance testing be performed for treatment-naive HIV-infected patients? A cost-effectiveness analysis. Clin Infect Dis. 2005;41(9):1316\u201323. doi:\n10.1086\/496984\n\n.","journal-title":"Clin Infect Dis"},{"key":"2708_CR11","unstructured":"Booth C. Transmitted resistance. In: Geretti AM, ed. Antiretroviral Resistance in Clinical Practice. London: Mediscript; 2006."},{"issue":"2","key":"2708_CR12","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1097\/QAD.0000000000000540","volume":"29","author":"M Helleberg","year":"2015","unstructured":"Helleberg M, May MT, Ingle SM, et al. Smoking and life expectancy among HIV-infected individuals on antiretroviral therapy in Europe and North America. AIDS. 2015;29(2):221\u20139. doi:\n10.1097\/QAD.0000000000000540\n\n.","journal-title":"AIDS"},{"key":"2708_CR13","doi-asserted-by":"crossref","unstructured":"Althoff KN, Smit M, Reiss P, Justice AC. HIV and ageing: improving quantity and quality of life. Curr Opin HIV AIDS. 2016;11(5). \nhttp:\/\/journals.lww.com\/co-hivandaids\/Fulltext\/2016\/09000\/HIV_and_ageing___improving_quantity_and_quality_of.12.aspx\n\n.","DOI":"10.1097\/COH.0000000000000305"},{"issue":"10","key":"2708_CR14","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1111\/j.1468-1293.2008.00637.x","volume":"9","author":"AM Geretti","year":"2008","unstructured":"Geretti AM, British HIV. Association guidelines for immunization of HIV-infected adults 2008. HIV Med. 2008;9(10):795\u2013848. doi:\n10.1111\/j.1468-1293.2008.00637.x\n\n.","journal-title":"HIV Med"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-017-2708-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,9,13]],"date-time":"2017-09-13T09:30:49Z","timestamp":1505295049000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-017-2708-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,13]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["2708"],"URL":"https:\/\/doi.org\/10.1186\/s12879-017-2708-y","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,13]]},"article-number":"619"}}